SUPN logo

Supernus Pharmaceuticals, Inc. (SUPN) Total debt

Annual Total Debt:

$34.27M-$7.26M(-17.47%)
December 31, 2024

Summary

  • As of today (September 12, 2025), SUPN annual total debt is $34.27 million, with the most recent change of -$7.26 million (-17.47%) on December 31, 2024.
  • During the last 3 years, SUPN annual total debt has fallen by -$392.76 million (-91.97%).
  • SUPN annual total debt is now -92.29% below its all-time high of $444.76 million, reached on December 31, 2022.

Performance

SUPN Total debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

Quarterly Total Debt:

$31.77M-$531.00K(-1.64%)
June 30, 2025

Summary

  • As of today (September 12, 2025), SUPN quarterly total debt is $31.77 million, with the most recent change of -$531.00 thousand (-1.64%) on June 30, 2025.
  • Over the past year, SUPN quarterly total debt has dropped by -$8.20 million (-20.52%).
  • SUPN quarterly total debt is now -93.95% below its all-time high of $524.95 million, reached on March 31, 2023.

Performance

SUPN Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

Total debt Formula

Total Debt = Short Term Debt + Long Term Debt

SUPN Total debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-17.5%-20.5%
3 y3 years-92.0%-92.9%
5 y5 years-91.5%-92.6%

SUPN Total debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-92.3%at low-94.0%at low
5 y5-year-92.3%at low-94.0%at low
alltimeall time-92.3%>+9999.0%-94.0%>+9999.0%

SUPN Total debt History

DateAnnualQuarterly
Jun 2025
-
$31.77M(-1.6%)
Mar 2025
-
$32.30M(-5.7%)
Dec 2024
$34.27M(-17.5%)
$34.27M(-10.2%)
Sep 2024
-
$38.15M(-4.6%)
Jun 2024
-
$39.98M(-5.1%)
Mar 2024
-
$42.13M(+1.4%)
Dec 2023
$41.53M(-90.7%)
$41.53M(-1.9%)
Sep 2023
-
$42.32M(+0.3%)
Jun 2023
-
$42.20M(-92.0%)
Mar 2023
-
$524.95M(+18.0%)
Dec 2022
$444.76M(+4.2%)
$444.76M(+0.1%)
Sep 2022
-
$444.22M(-0.5%)
Jun 2022
-
$446.39M(-0.8%)
Mar 2022
-
$450.20M(+5.4%)
Dec 2021
$427.03M(-1.0%)
$427.03M(+0.2%)
Sep 2021
-
$426.09M(+0.9%)
Jun 2021
-
$422.45M(-2.6%)
Mar 2021
-
$433.75M(+0.5%)
Dec 2020
$431.50M(+7.6%)
$431.50M(-0.5%)
Sep 2020
-
$433.54M(+0.7%)
Jun 2020
-
$430.58M(+6.2%)
Mar 2020
-
$405.52M(+1.1%)
Dec 2019
$400.93M(+13.2%)
$400.93M(+1.5%)
Sep 2019
-
$394.83M(+0.8%)
Jun 2019
-
$391.87M(+0.8%)
Mar 2019
-
$388.77M(+9.8%)
Dec 2018
$354.22M(+1234.6%)
$354.22M(+1.0%)
Sep 2018
-
$350.86M(+1.0%)
Jun 2018
-
$347.45M(+1.0%)
Mar 2018
-
$344.03M(+1196.2%)
Dec 2017
$26.54M
$26.54M(-5.1%)
DateAnnualQuarterly
Sep 2017
-
$27.96M(-8.8%)
Jun 2017
-
$30.65M(-8.5%)
Mar 2017
-
$33.51M(-3.0%)
Dec 2016
$34.55M(-8.1%)
$34.55M(+498.7%)
Sep 2016
-
$5.77M(+1.3%)
Jun 2016
-
$5.70M(+1.3%)
Mar 2016
-
$5.63M(-85.0%)
Dec 2015
$37.61M(+39.6%)
$37.61M(+366.2%)
Sep 2015
-
$8.07M(-6.3%)
Jun 2015
-
$8.61M(-25.0%)
Mar 2015
-
$11.48M(-57.4%)
Dec 2014
$26.95M(-21.6%)
$26.95M(+1.7%)
Sep 2014
-
$26.50M(-7.6%)
Jun 2014
-
$28.67M(+1.1%)
Mar 2014
-
$28.36M(-17.5%)
Dec 2013
$34.39M(+50.2%)
$34.39M(-42.8%)
Sep 2013
-
$60.17M(+1.8%)
Jun 2013
-
$59.10M(+193.9%)
Mar 2013
-
$20.11M(-12.2%)
Dec 2012
$22.90M(-22.3%)
$22.90M(-10.6%)
Sep 2012
-
$25.61M(-7.9%)
Jun 2012
-
$27.81M(-4.4%)
Mar 2012
-
$29.10M(-1.3%)
Dec 2011
$29.49M(>+9900.0%)
$29.49M(-67.1%)
Sep 2011
-
$89.51M(>+9900.0%)
Jun 2011
-
$0.00(0.0%)
Mar 2011
-
$0.00(0.0%)
Dec 2010
$0.00(-100.0%)
$0.00(-100.0%)
Sep 2010
-
$75.00M(0.0%)
Dec 2009
$75.00M(0.0%)
$75.00M
Dec 2008
$75.00M(>+9900.0%)
-
Dec 2007
$0.00
-

FAQ

  • What is Supernus Pharmaceuticals, Inc. annual total debt?
  • What is the all time high annual total debt for Supernus Pharmaceuticals, Inc.?
  • What is Supernus Pharmaceuticals, Inc. annual total debt year-on-year change?
  • What is Supernus Pharmaceuticals, Inc. quarterly total debt?
  • What is the all time high quarterly total debt for Supernus Pharmaceuticals, Inc.?
  • What is Supernus Pharmaceuticals, Inc. quarterly total debt year-on-year change?

What is Supernus Pharmaceuticals, Inc. annual total debt?

The current annual total debt of SUPN is $34.27M

What is the all time high annual total debt for Supernus Pharmaceuticals, Inc.?

Supernus Pharmaceuticals, Inc. all-time high annual total debt is $444.76M

What is Supernus Pharmaceuticals, Inc. annual total debt year-on-year change?

Over the past year, SUPN annual total debt has changed by -$7.26M (-17.47%)

What is Supernus Pharmaceuticals, Inc. quarterly total debt?

The current quarterly total debt of SUPN is $31.77M

What is the all time high quarterly total debt for Supernus Pharmaceuticals, Inc.?

Supernus Pharmaceuticals, Inc. all-time high quarterly total debt is $524.95M

What is Supernus Pharmaceuticals, Inc. quarterly total debt year-on-year change?

Over the past year, SUPN quarterly total debt has changed by -$8.20M (-20.52%)
On this page